Aspire Private Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Aspire Private Capital's AMGN Position: Q4 2024 in Review
Aspire Private Capital sold out of Amgen (AMGN) in Q4 2024, closing a stake of 300 shares — an estimated $96.6K sold.
Aspire Private Capital first reported a position in AMGN in Q4 2018 and held it in 24 quarters. The position peaked at $349K in Q4 2019. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Aspire Private Capital reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Aspire Private Capital sold 300 Amgen shares in Q4 2024, an estimated $96.6K.
- Aspire Private Capital first reported a position in Amgen in Q4 2018 and held it in 24 quarters.
- Aspire Private Capital's Amgen position peaked at $349K in Q4 2019.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.